We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$942M
AUM Growth
+$47.5M
Cap. Flow
+$57.7M
Cap. Flow %
6.13%
Top 10 Hldgs %
36.92%
Holding
174
New
107
Increased
33
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$22.8M
2
FOLD
Amicus Therapeutics
FOLD
+$16.4M
3
COLL icon
Collegium Pharmaceutical
COLL
+$15.5M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.7M
5
AERI
Aerie Pharmaceuticals
AERI
+$10.4M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$24.4M
2
MOH icon
Molina Healthcare
MOH
+$17.5M
3
EXAS
Exact Sciences
EXAS
+$14.2M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$13.9M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 0.89%
3 Technology 0.84%
4 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
26
DELISTED
Clovis Oncology, Inc.
CLVS
$13M 1.38%
443,397
+74,698
+20% +$2.89M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$13M 1.38%
447,572
+139,900
+45% +$3.77M
ABMD
28
DELISTED
Abiomed Inc
ABMD
$12.9M 1.37%
28,668
-16,598
-37% -$6.54M
MDT icon
29
Medtronic
MDT
$111B
$12.9M 1.37%
130,851
-16,949
-11% -$1.57M
HRC
30
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$12.6M 1.34%
133,337
+42,737
+47% +$4.01M
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
$12.3M 1.3%
88,399
-91,901
-51% -$11.5M
COGT icon
32
Cogent Biosciences
COGT
$6.95B
$10.8M 1.14%
261,736
-8,650
-3% -$488K
PODD icon
33
Insulet
PODD
$11.6B
$10.2M 1.08%
96,360
+1,851
+2% +$173K
OBSV
34
DELISTED
ObsEva SA Ordinary Shares
OBSV
$10.2M 1.08%
564,692
+26,541
+5% +$390K
ALDR
35
DELISTED
Alder Biopharmaceuticals
ALDR
$10.2M 1.08%
609,612
-429,288
-41% -$7.76M
VRAY
36
DELISTED
ViewRay, Inc.
VRAY
$9.89M 1.05%
1,056,164
+90,100
+9% +$886K
CI icon
37
Cigna
CI
$79.6B
$9.69M 1.03%
46,530
+592
+1% +$110K
BSX icon
38
Boston Scientific
BSX
$68.5B
$9.68M 1.03%
251,376
+61,476
+32% +$2.15M
PTCT icon
39
PTC Therapeutics
PTCT
$6.25B
$9.6M 1.02%
204,237
+68,353
+50% +$2.83M
GBT
40
DELISTED
Global Blood Therapeutics, Inc.
GBT
$9.05M 0.96%
238,041
+7,347
+3% +$325K
SVRA icon
41
Savara
SVRA
$1.09B
$9M 0.96%
806,500
+475,000
+143% +$5.46M
ATRC icon
42
AtriCure
ATRC
$2.01B
$8.79M 0.93%
+250,824
New +$7.94M
ABT icon
43
Abbott
ABT
$187B
$8.03M 0.85%
109,398
+15,499
+17% +$1.02M
VCRA
44
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$7.95M 0.84%
217,349
+86,699
+66% +$2.84M
RCM
45
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.47M 0.79%
+735,723
New +$6.7M
INDP icon
46
Indaptus Therapeutics
INDP
$231M
$6.65M 0.71%
525
+128
+32% +$1.22M
RARX
47
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$6.31M 0.67%
+348,712
New +$4.13M
ALBO
48
DELISTED
Albireo Pharma Inc
ALBO
$6.25M 0.66%
189,578
+16,775
+10% +$549K
LLY icon
49
Eli Lilly
LLY
$1.09T
$5.98M 0.64%
55,766
-66,834
-55% -$6.68M
MGTX icon
50
MeiraGTx Holdings
MGTX
$1.09B
$5.55M 0.59%
407,906
+32,906
+9% +$356K
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sectoral Asset Management held 174 positions worth $942M, up 5.3% from $894M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management deployed $57.7M of net new capital in Q3 2018, opening 107 new positions and adding to 33 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $24.4M trimmed.

  • Sectoral Asset Management's largest Q3 2018 buy was Vertex Pharmaceuticals: 76,846 shares worth $14.8M.
  • Sectoral Asset Management added most to Celgene Corp in Q3 2018, an estimated $22.8M increase.
  • Sectoral Asset Management's biggest Q3 2018 reduction was Sarepta Therapeutics, cutting an estimated $24.4M.
  • Sectoral Asset Management fully exited Molina Healthcare in Q3 2018, selling an estimated $17.5M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $942M portfolio in Q3 2018.
  • Sectoral Asset Management opened 107 new positions and closed 6 in Q3 2018.
  • Sectoral Asset Management's portfolio value rose 5.3% quarter-over-quarter to $942M.

Based on Sectoral Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.